Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hunan Clinical Research Center of Ophthalmic Disease, Changsha, Hunan, China.
Transl Vis Sci Technol. 2024 Aug 1;13(8):32. doi: 10.1167/tvst.13.8.32.
This study aimed to reveal the altered expressions of transfer RNA (tRNA)-derived small RNAs (tsRNAs) in peripheral blood mononuclear cells and identify potential diagnostic biomarkers for nonproliferative diabetic retinopathy (NPDR) from patients with type 2 diabetes mellitus.
Fifty-three patients diagnosed with type 2 diabetes mellitus were enrolled, including 25 patients with NPDR and 28 patients without diabetic retinopathy (DR) as the control group. A small RNA microarray was performed to screen the differentially expressed tsRNAs. Reverse transcriptase quantitative polymerase chain reaction was used to validate the significantly altered tsRNAs in a screening cohort and a verification cohort. The target genes, their enriched functions, and signaling pathways were predicted by bioinformatics analyses.
In total, 668 upregulated and 485 downregulated tsRNAs were found in the NPDR group by microarray. Eight tsRNAs were validated preliminarily to be altered significantly by reverse transcriptase quantitative polymerase chain reaction, and their target genes were enriched in cellular macromolecule metabolic process and ubiquitin-mediated proteolysis. The verification experiments confirmed the increased levels of 5'tiRNA-35-PheGAA-8, tRF3-28-PheGAA-1, and tRF3b-PheGAA-6, and the decreased levels of mt-tRF3-19-ArgTCG, mt-tRF3-20-ArgTCG, and mt-tRF3-21-ArgTCG in patients with NPDR, which may serve as potential biomarkers with clinical significance.
The study recognized the tsRNA expression changes in peripheral blood mononuclear cells from patients with NPDR and discovered potential diagnostic biomarkers that hold clinical significance.
The significantly altered tsRNAs identified in the study may serve as potential diagnostic biomarkers for patients with NPDR as well as possible molecular targets of the occurrence and development of DR.
本研究旨在揭示 2 型糖尿病患者外周血单个核细胞中转录 RNA(tRNA)衍生的小 RNA(tsRNA)的表达变化,并鉴定出非增殖性糖尿病视网膜病变(NPDR)的潜在诊断生物标志物。
共纳入 53 例 2 型糖尿病患者,包括 25 例 NPDR 患者和 28 例无糖尿病视网膜病变(DR)的对照组患者。采用小 RNA 微阵列筛选差异表达的 tsRNA。采用逆转录定量聚合酶链反应(RT-qPCR)在筛选队列和验证队列中验证明显改变的 tsRNA。通过生物信息学分析预测靶基因、其富集功能和信号通路。
通过微阵列共发现 NPDR 组中 668 个上调和 485 个下调的 tsRNA。RT-qPCR 初步验证了 8 个 tsRNA 显著改变,其靶基因在细胞大分子代谢过程和泛素介导的蛋白水解中富集。验证实验证实了 5'tiRNA-35-PheGAA-8、tRF3-28-PheGAA-1 和 tRF3b-PheGAA-6 的水平升高,以及 mt-tRF3-19-ArgTCG、mt-tRF3-20-ArgTCG 和 mt-tRF3-21-ArgTCG 的水平降低在 NPDR 患者中,这些可能是具有临床意义的潜在生物标志物。
本研究发现了 NPDR 患者外周血单个核细胞中 tsRNA 的表达变化,并发现了具有临床意义的潜在诊断生物标志物。
温志华